Holen Sie sich die Stockscreener-App
18.68
2.36%
0.43
Vorhandelsmarkt:
18.54
-0.14
-0.75%
Schlusskurs vom Vortag:
$18.25
Offen:
$18.04
24-Stunden-Volumen:
27,540
Relative Volume:
1.01
Marktkapitalisierung:
$142.67M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-61.23M
KGV:
-1.3817
EPS:
-13.5194
Netto-Cashflow:
$22.49M
1W Leistung:
+0.21%
1M Leistung:
+7.42%
6M Leistung:
+24.95%
1J Leistung:
+24.20%
1-Tages-Spanne:
$17.57
$18.90
1-Wochen-Bereich:
$17.57
$19.50
52-Wochen-Spanne:
$7.75
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie ASMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
18.68 | 142.36M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Is Assembly Biosciences Inc. a good long term investmentExplosive returns - Autocar Professional
What analysts say about Assembly Biosciences Inc. stockExplosive trading opportunities - jammulinksnews.com
What drives Assembly Biosciences Inc. stock priceHigh-velocity gains - Autocar Professional
What analysts say about GDEV stockMassive wealth growth - Autocar Professional
When the Price of (ASMB) Talks, People Listen - news.stocktradersdaily.com
Assembly Biosciences Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - jammulinksnews.com
What analysts say about Tectonic Therapeutic Inc. stock outlookCarefully Curated High Return Stocks - Newser
How NNAGR stock performs during market volatilityShort Term Profit Focus - Newser
What makes Assembly Biosciences Inc. stock price move sharplyReturn Optimized Trade Insights - Newser
What makes SKLZ stock price move sharplyMarket Trend Watch - Newser
When BATRK stock expected to show significant growthIs CHRS stock a good long term investment optionFree Stock Market Trend Analysis - Newser
How Assembly Biosciences Inc. stock performs during market volatilityReturn Maximized Portfolio Strategy - Newser
Why Assembly Biosciences Inc. stock attracts strong analyst attentionSafe and Smart Investment Picks - Newser
What makes Trupanion Inc. stock price move sharplyStrong Return Daily Alerts - Newser
How CMCL stock performs during market volatilityFree Wealth-Building Investment Strategies - Newser
Is It Worth Buying TRINITY(trinityswap)Free Professional Portfolio Management - Newser
(ASMB) On The My Stocks Page - news.stocktradersdaily.com
Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes - Insider Monkey
Hepatitis D Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179 - The Manila Times
Assembly Biosciences (ASMB) Reports Positive Phase 1b Results fo - GuruFocus
15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey
Assembly Biosciences reports positive topline results from Phase 1b clinical trial of ABI-4334 in hepatitis B - European AIDS Treatment Group
Assembly Bio reports positive results from HBV drug trial - Investing.com
Assembly Biosciences at a Tipping Point: ABI-4334's Data Sparks Gilead's Strategic Choice for HBV Cure Leadership - AInvest
Assembly Biosciences, Inc. (NASDAQ:ASMB) stock most popular amongst individual investors who own 48%, while public companies hold 29% - Yahoo Finance
Where are the Opportunities in (ASMB) - news.stocktradersdaily.com
Assembly Biosciences describes new azetidine compounds for HSV infections - BioWorld MedTech
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 47.1% in May - Defense World
Live Biotherapeutic Products and Microbiome CDMO Market Size to Hit USD 1,496.69 Mn by 2034 - Precedence Research
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World
Assembly Biosciences expands stock plans, appoints new CFO - Investing.com India
Assembly Biosciences expands stock plans, appoints new CFO By Investing.com - Investing.com Nigeria
Assembly Biosciences Announces Stock Plan Amendments and Leadership Change - TipRanks
Assembly Biosciences IncJeanette M. Bjorkquist Appointed Principal Financial Officer On June 5- SEC Filing - MarketScreener
(ASMB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Assembly Biosciences, Inc. (NASDAQ:ASMB) Shares Sold by Northern Trust Corp - Defense World
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):